✦ LIBER ✦

Nested Case Control Study of Proteomic Biomarkers for Interstitial Lung Disease in Japanese Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib: A Multicenter Phase IV Study (JO21661)

✍ Scribed by Atagi, Shinji; Katakami, Nobuyuki; Yoshioka, Hiroshige; Fukuoka, Masahiro; Kudoh, Shoji; Ogiwara, Atsushi; Imai, Masato; Ueda, Masamichi; Matsui, Shigeyuki

Book ID: 123127858
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 976 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.12.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of enzastaurin in combi

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

✍ Clément-Duchêne, Christelle; Natale, Ronald B.; Jahan, Thierry; Krupitskaya, Yel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

9174 Phase II study of everolimus plus e

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P-629 A phase I study of erlotinib (Tarc

P-629 A phase I study of erlotinib (TarcevaTM) monotherapy in Japanese patients with non-small cell lung cancer and other solid tumors

✍ Atsushi, Horiike; Yamada, Yasuhide; Yamamoto, Noboru; Shimoyama, Tatsu; Murakami 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

A prospective, phase II, open-label stud

A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)

✍ Goto, Koichi; Nishio, Makoto; Yamamoto, Noboru; Chikamori, Kenichi; Hida, Toyoak 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 948 KB

6513 ORAL A phase II study of erlotinib

6513 ORAL A phase II study of erlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC)

✍ Dingemans, A.; Groen, H.J.M.; Smit, E.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

6587 POSTER A phase IB, dose-finding stu

6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study

✍ Ranson, M.; Reck, M.; Anthoney, A.; Hanauske, A.; Akimov, M.; Klingelschmitt, G. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB